Jeff Yass’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $325K | Sell |
6,876
-38,086
| -85% | -$1.96M | ﹤0.01% | 10866 |
|
|
2026
Q1 | $2.66M | Buy |
44,962
+34,930
| +348% | +$2.27M | ﹤0.01% | 5523 |
|
|
2025
Q4 | $619K | Buy |
10,032
+1,500
| +18% | +$91.8K | ﹤0.01% | 8309 |
|
|
2025
Q3 | $532K | Sell |
8,532
-52,924
| -86% | -$3.68M | ﹤0.01% | 8794 |
|
|
2025
Q2 | $4.91M | Sell |
61,456
-7,687
| -11% | -$643K | ﹤0.01% | 4010 |
|
|
2025
Q1 | $5.94M | Buy |
69,143
+47,954
| +226% | +$3.93M | ﹤0.01% | 3327 |
|
|
2024
Q4 | $1.65M | Buy |
21,189
+11,475
| +118% | +$891K | ﹤0.01% | 5726 |
|
|
2024
Q3 | $700K | Buy |
+9,714
| New | +$688K | ﹤0.01% | 7657 |
|
|
2024
Q2 | – | Sell |
-4,192
| Closed | -$284K | – | 12926 |
|
|
2024
Q1 | $304K | Sell |
4,192
-14,146
| -77% | -$946K | ﹤0.01% | 9668 |
|
|
2023
Q4 | $1.12M | Buy |
18,338
+2,002
| +12% | +$119K | ﹤0.01% | 6717 |
|
|
2023
Q3 | $934K | Sell |
16,336
-3,129
| -16% | -$189K | ﹤0.01% | 6771 |
|
|
2023
Q2 | $1.16M | Sell |
19,465
-5,587
| -22% | -$334K | ﹤0.01% | 6344 |
|
|
2023
Q1 | $1.57M | Buy |
25,052
+18,627
| +290% | +$1.16M | ﹤0.01% | 5695 |
|
|
2022
Q4 | $402K | Sell |
6,425
-19,563
| -75% | -$1.12M | ﹤0.01% | 8379 |
|
|
2022
Q3 | $1.29M | Buy |
+25,988
| New | +$1.44M | ﹤0.01% | 5970 |
|
|
2022
Q2 | – | Sell |
-4,710
| Closed | -$260K | – | 13666 |
|
|
2022
Q1 | $249K | Sell |
4,710
-5,438
| -54% | -$314K | ﹤0.01% | 10729 |
|
|
2021
Q4 | $615K | Buy |
10,148
+4,314
| +74% | +$256K | ﹤0.01% | 8601 |
|
|
2021
Q3 | $327K | Sell |
5,834
-16,548
| -74% | -$909K | ﹤0.01% | 10407 |
|
|
2021
Q2 | $1.17M | Buy |
22,382
+14,797
| +195% | +$711K | ﹤0.01% | 7333 |
|
|
2021
Q1 | $334K | Sell |
7,585
-60,736
| -89% | -$2.55M | ﹤0.01% | 10380 |
|
|
2020
Q4 | $2.38M | Buy |
68,321
+58,418
| +590% | +$2.07M | ﹤0.01% | 4736 |
|
|
2020
Q3 | $361K | Buy |
+9,903
| New | +$368K | ﹤0.01% | 8338 |
|
|
2020
Q2 | – | Sell |
-20,559
| Closed | -$822K | – | 10700 |
|
|
2020
Q1 | $754K | Buy |
20,559
+12,642
| +160% | +$491K | ﹤0.01% | 6014 |
|
|
2019
Q4 | $321K | Sell |
7,917
-16,323
| -67% | -$609K | ﹤0.01% | 7887 |
|
|
2019
Q3 | $841K | Buy |
24,240
+5,877
| +32% | +$194K | ﹤0.01% | 6080 |
|
|
2019
Q2 | $582K | Buy |
+18,363
| New | +$546K | ﹤0.01% | 6963 |
|
|
2019
Q1 | – | Sell |
-13,274
| Closed | -$380K | – | 9570 |
|
|
2018
Q4 | $410K | Buy |
+13,274
| New | +$484K | ﹤0.01% | 6398 |
|
|
2017
Q1 | – | Sell |
-84,337
| Closed | -$4.65M | – | 9681 |
|
|
2016
Q4 | $4.39M | Buy |
+84,337
| New | +$4.07M | ﹤0.01% | 2628 |
|
|
2016
Q2 | – | Sell |
-47,288
| Closed | -$2.6M | – | 9132 |
|
|
2016
Q1 | $2.52M | Sell |
47,288
-16,963
| -26% | -$835K | ﹤0.01% | 3331 |
|
|
2015
Q4 | $3.31M | Sell |
64,251
-41,818
| -39% | -$2.08M | ﹤0.01% | 3114 |
|
|
2015
Q3 | $4.79M | Buy |
106,069
+54,579
| +106% | +$2.58M | ﹤0.01% | 2729 |
|
|
2015
Q2 | $2.38M | Buy |
51,490
+11,457
| +29% | +$501K | ﹤0.01% | 4342 |
|
|
2015
Q1 | $1.72M | Sell |
40,033
-54,124
| -57% | -$2.06M | ﹤0.01% | 4602 |
|
|
2014
Q4 | $3.27M | Buy |
94,157
+53,957
| +134% | +$1.79M | ﹤0.01% | 3584 |
|
|
2014
Q3 | $1.3M | Sell |
40,200
-23,817
| -37% | -$797K | ﹤0.01% | 5412 |
|
|
2014
Q2 | $2.17M | Sell |
64,017
-4,365
| -6% | -$140K | ﹤0.01% | 4515 |
|
|
2014
Q1 | $1.86M | Buy |
68,382
+55,619
| +436% | +$1.65M | ﹤0.01% | 4461 |
|
|
2013
Q4 | $457K | Sell |
12,763
-13,637
| -52% | -$453K | ﹤0.01% | 6855 |
|
|
2013
Q3 | $795K | Sell |
26,400
-18,754
| -42% | -$613K | ﹤0.01% | 5690 |
|
|
2013
Q2 | $1.31M | Buy |
+45,154
| New | +$1.27M | ﹤0.01% | 4555 |
|
Other funds holding PBH
AI
BIP
Jeff Yass's PBH Position: Q2 2026 in Review
Jeff Yass reduced its Prestige Consumer Healthcare (PBH) stake by 85% in Q2 2026, selling an estimated $1.96M and leaving 6,876 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #10866.
Jeff Yass first reported a position in PBH in Q2 2013 and has held it in 40 quarters since. The position peaked at $5.94M in Q1 2025. 318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Jeff Yass held 6,876 shares of Prestige Consumer Healthcare worth $325K as of Q2 2026.
- Jeff Yass sold 38,086 Prestige Consumer Healthcare shares in Q2 2026, an estimated $1.96M.
- Prestige Consumer Healthcare made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #10866 holding.
- Jeff Yass first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 40 quarters since.
- Jeff Yass's Prestige Consumer Healthcare position peaked at $5.94M in Q1 2025.
- 318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.